Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...

Private equity firm Sycamore Partners has been speaking with private credit firms about debt financing for a potential Walgreens deal, according to people familiar with the matter, despite an ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...

NEW YORK: Sycamore Partners said it would acquire US office supplies chain Staples Inc for US$6.9bil, a rare bet by a private equity firm this year in the US retail sector, which has been roiled ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Find out why Walgreens Boots Alliance (WBA) stock fell over 7% in extended trading and why the drugstore chain is suspending ...

Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...